FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Didanosine Delayed-Release Capsules USP
Status: Discontinuation
»Therapeutic Categories: Antiviral

Expand all

Teva Pharmaceuticals (New 05/09/2018)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
Didanosine Delayed-Release Capsules, USP, 200 mg, 30 count bottles (NDC 0555-0588-01) 05/09/2018 This was a business-related decision to discontinue manufacturing these products
Didanosine Delayed-Release Capsules, USP, 250 mg, 30 count bottles (NDC 0555-0589-01) 05/09/2018 This was a business-related decision to discontinue manufacturing these products
Didanosine Delayed-Release Capsules, USP, 400 mg, 30 count bottles (NDC 0555-0590-01) 05/09/2018 This was a business-related decision to discontinue manufacturing these products

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English